Enhanced immune protection by a liposome-encapsulated recombinant respiratory syncytial virus (RSV) vaccine using immunogenic lipids from Deinococcus radiodurans

Author： Huang Y.   Anderson R.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.11, 2002-02, pp. : 1586-1592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liposome encapsulation of a soluble recombinant fragment of the respiratory syncytial virus (RSV) G protein enhances immune protection and reduces lung eosinophilia associated with virus challenge

By Mader D.   Huang Y.   Wang C.   Fraser R.   Issekutz A.C.   Stadnyk A.W.   Anderson R.  

Vaccine, Vol. 18, Iss. 11, 2000-01 ,pp. : 1110-1117

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the Western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection

By Piedra P.A.   Glezen W.P.   Kasel J.A.   Welliver R.C.   Jewel A.M.   Rayford Y.   Hogerman D.A.   Hildreth S.W.   Paradiso P.R.  

Vaccine, Vol. 13, Iss. 12, 1995-08 ,pp. : 1095-1101

Elsevier

Access to resources Recommend Favorite

Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides

By Cano F.   Plotnicky-Gilquin H.   Nguyen T.N.   Liljeqvist S.   Samuelson P.   Bonnefoy J.-Y.   Stahl S.   Robert A.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2743-2752

Elsevier

Access to resources Recommend Favorite

Dose-dependent effects of IL-12 treatment to immune response induced after immunization with a recombinant respiratory syncytial virus (RSV) fusion protein fragment

By Werle B.   Fromantin C.   Alexandre A.   Kohli E.   Pothier P.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 2983-2990

Elsevier

Access to resources Recommend Favorite

Influence of live respiratory syncytial virus priming on the immune response generated by a recombinant vaccine candidate, BBG2Na

By Goestch L.   Plotnicky-Gilquin H.   Champion T.   Beck A.   Haeuw J.F.   Nguyen T.   Bonnefoy J.Y.   Corvaa N.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2648-2655

Elsevier

Access to resources Recommend Favorite